KT095
/ Nanjing KATI
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 25, 2022
B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: The First People's Hospital of Lianyungang
CAR T-Cell Therapy • New P1 trial • Gastrointestinal Cancer • Gastrointestinal Disorder • Oncology • Solid Tumor • CD276
1 to 1
Of
1
Go to page
1